GE completes FDA submission for breast tomosynthesis technology

07/31/2013 | AuntMinnie.com (free registration)

GE Healthcare said the final module of its premarket approval application for the GE Breast Tomosynthesis system has been forwarded to the FDA. The technology, which serves as an add-on option for the company's Senographe Essential device, delivers 3D digital images of the breast to aid in the detection of breast cancer.

View Full Article in:

AuntMinnie.com (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX